Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice.
Nadauld LD, McDonnell CH 3rd, Beer TM, Liu MC, Klein EA, Hudnut A, Whittington RA, Taylor B, Oxnard GR, Lipson J, Lopatin M, Shaknovich R, Chung KC, Fung ET, Schrag D, Marinac CR. Nadauld LD, et al. Among authors: lipson j. Cancers (Basel). 2021 Jul 13;13(14):3501. doi: 10.3390/cancers13143501. Cancers (Basel). 2021. PMID: 34298717 Free PMC article.
Clinical correlates of circulating cell-free DNA tumor fraction.
Bredno J, Lipson J, Venn O, Aravanis AM, Jamshidi A. Bredno J, et al. Among authors: lipson j. PLoS One. 2021 Aug 25;16(8):e0256436. doi: 10.1371/journal.pone.0256436. eCollection 2021. PLoS One. 2021. PMID: 34432811 Free PMC article.
A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.
Vinayak S, Schwartz EJ, Jensen K, Lipson J, Alli E, McPherson L, Fernandez AM, Sharma VB, Staton A, Mills MA, Schackmann EA, Telli ML, Kardashian A, Ford JM, Kurian AW. Vinayak S, et al. Among authors: lipson j. Breast Cancer Res Treat. 2013 Nov;142(2):389-98. doi: 10.1007/s10549-013-2739-z. Epub 2013 Oct 29. Breast Cancer Res Treat. 2013. PMID: 24166281 Free PMC article. Clinical Trial.
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.
Telli ML, Jensen KC, Vinayak S, Kurian AW, Lipson JA, Flaherty PJ, Timms K, Abkevich V, Schackmann EA, Wapnir IL, Carlson RW, Chang PJ, Sparano JA, Head B, Goldstein LJ, Haley B, Dakhil SR, Reid JE, Hartman AR, Manola J, Ford JM. Telli ML, et al. Among authors: lipson ja. J Clin Oncol. 2015 Jun 10;33(17):1895-901. doi: 10.1200/JCO.2014.57.0085. Epub 2015 Apr 6. J Clin Oncol. 2015. PMID: 25847929 Free PMC article. Clinical Trial.
The California breast density information group: a collaborative response to the issues of breast density, breast cancer risk, and breast density notification legislation.
Price ER, Hargreaves J, Lipson JA, Sickles EA, Brenner RJ, Lindfors KK, Joe BN, Leung JW, Feig SA, Bassett LW, Ojeda-Fournier H, Daniel BL, Kurian AW, Love E, Ryan L, Walgenbach DD, Ikeda DM. Price ER, et al. Among authors: lipson ja. Radiology. 2013 Dec;269(3):887-92. doi: 10.1148/radiol.13131217. Epub 2013 Oct 28. Radiology. 2013. PMID: 24023072
148 results